Effects of Continuous Perioperative Esketamine Infusion on Postoperative Depression in Breast Cancer Patients: A Randomized Controlled Double-Blind Trial.

Drug Des Devel Ther October 29, 2025 DOI: 10.2147/dddt.s540781 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Randomized Double-blind Peer reviewed
Topics	Depression Esketamine

Abstract

Effects of Continuous Perioperative Esketamine Infusion on Postoperative Depression in Breast Cancer Patients: A Randomized Controlled Double-Blind Trial.

Effect of esketamine on postoperative depression in women with breast cancer and preoperative depressive symptoms: The EASE randomized trial. Journal of clinical anesthesia April 1, 2025 10 citations
Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study. BMC Psychiatry February 9, 2026
Efficacy and safety of perioperative esketamine for postoperative depressive symptoms in breast cancer patients: a meta-analysis Frontiers in Pharmacology July 8, 2026
Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial. Front Psychiatry March 15, 2023
Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: A randomized, double-blinded controlled trial. Medicine (Baltimore) March 1, 2023

Study at a glance

Abstract

Related reading